PPC
ATRC icon

Park Place Capital’s AtriCure ATRC Stock Holding History

Park Place Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31
Closed -$706 – 858
2024
Q2 		$706 Sell
31
-85
-73% -$1.96K ﹤0.01% 844
2024
Q1 		$3.53K Buy
116
+31
+36% +$1.04K ﹤0.01% 769
2023
Q4 		$3.03K Sell
85
-445
-84% -$16.6K ﹤0.01% 764
2023
Q3 		$23.2K Hold
530
– – 0.01% 604
2023
Q2 		$26.2K Hold
530
– – 0.01% 604
2023
Q1 		$22K Buy
530
+123
+30% +$5.1K 0.01% 630
2022
Q4 		$18K Buy
+407
New +$17K 0.01% 669

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Park Place Capital's ATRC Position: Q3 2024 in Review

Park Place Capital sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 31 shares — an estimated $706 sold.

Park Place Capital first reported a position in ATRC in Q4 2022 and held it in 7 quarters. The position peaked at $26.2K in Q2 2023. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • Park Place Capital reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
  • Park Place Capital sold 31 AtriCure shares in Q3 2024, an estimated $706.
  • Park Place Capital first reported a position in AtriCure in Q4 2022 and held it in 7 quarters.
  • Park Place Capital's AtriCure position peaked at $26.2K in Q2 2023.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Park Place Capital's 13F filing for Q3 2024, filed 8 Oct 2024.